Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login



Penicillin allergy associated with increased risk of superbug infections

Methicillin-resistant Streptococcus aureus

Source: Shutterstock

It was found that the risk of MRSA and C. difficile infections increased by 69% and 26%, respectively, among patients with penicillin allergy

Penicillin allergy is associated with an increased risk of methicillin-resistant Staphylococcus aureus (MRSA) and Clostridioides difficile (C. difficile) mediated by the increased use of ‘broad spectrum’ antibiotics, a study in The British Medical Journal has found[1].

The matched cohort study enrolled 301,399 adults without previous MRSA or C. difficile, 64,141 of whom had a penicillin allergy recorded in their medical records.

During the mean follow-up time of 6 years, 442 patients with penicillin allergy and 923 of the comparator patients developed MRSA; 442 patients with penicillin allergy and 1,249 comparator patients developed C. difficile.

Among patients with penicillin allergy it was found that the risk of MRSA and C. difficile increased by 69% and 26%, respectively, even after adjusting for several known risk factors.

Penicillin allergy also resulted in an increased use of beta-lactam alternative antibiotics, including a fourfold increased incidence of macrolides and clindamycin use and a twofold increased incidence of fluoroquinolone use.

The researchers found that increased use of beta-lactam alternative antibiotics accounted for 55% of the increased risk of MRSA and 35% of the increased risk of C. difficile.

They said that the results emphasise that outpatient use of antibiotics is strongly associated with the risk of developing MRSA.

“Systematically addressing penicillin allergies may be an important public health strategy to reduce the incidence of MRSA and C. difficile among patients with a penicillin allergy label,” the authors concluded.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205073

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Chronotherapeutics


    Chronotherapeutics discusses the pharmaceutical and therapeutic implications associated with biological clocks in humans.

    £38.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Methicillin-resistant Streptococcus aureus

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.